SCHEMBL1302144

SCHEMBL1302144

CC1(C)c2ccccc2N(C(=O)O)c2ccc(-c3ccc(Br)cc3)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ LMNA P02545 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ HDAC2 Q92769 1/20 0.38
▸ MCL1 Q07820 3/20 0.37
▸ ACHE P22303 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ MMP14 P50281 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.36
▸ HSD17B3 P37058 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3718415 0.84 MAPK1 (0.39) MAPTALDH1A1MAPK1LMNAMEN1
SCHEMBL1302564 0.84 HSD17B3 (0.35) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL12109382 0.83 BCHE (0.45) MAPTALDH1A1MAPK1LMNAMEN1
SCHEMBL15046447 0.81 PGR (0.44) MAPTALDH1A1MAPK1LMNAMEN1
SCHEMBL15046283 0.81 PGR (0.44) MAPTALDH1A1MAPK1LMNAMEN1
SCHEMBL1302565 0.78 MAPK13 (0.38) ALDH1A1MEN1KMT2AHDAC2L3MBTL1
SCHEMBL17853028 0.74 HTT (0.44) MAPTALDH1A1MAPK1LMNAMEN1
SCHEMBL15773108 0.74 ALDH1A1 (0.43) MAPTALDH1A1MAPK1MEN1KMT2A
SCHEMBL15773099 0.73 ALDH1A1 (0.37) MAPTALDH1A1MAPK1LMNAMEN1
SCHEMBL15773098 0.73 ALDH1A1 (0.37) MAPTALDH1A1MAPK1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034485-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2015-05-19 — — US disclosed
US-20110266533-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-11-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110266533-A1 COMPOUNDS FOR ELECTRONIC DEVICES SLCO2A1, SLC40A1, TOE1 MAPT 1198/4885ALDH1A1 173/4885MAPK1 586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback